Squarepoint’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.4M Buy
604,000
+213,048
+54% +$2.92M 0.02% 1166
2025
Q4
$5.4M Buy
390,952
+324,791
+491% +$7.64M 0.01% 1406
2025
Q3
$1.62M Sell
66,161
-123,408
-65% -$3.01M ﹤0.01% 2278
2025
Q2
$4.38M Buy
189,569
+132,121
+230% +$3.48M 0.01% 1547
2025
Q1
$1.55M Buy
57,448
+16,272
+40% +$613K ﹤0.01% 2299
2024
Q4
$2.2M Buy
41,176
+25,034
+155% +$1.32M 0.01% 2327
2024
Q3
$733K Sell
16,142
-16,720
-51% -$727K ﹤0.01% 2837
2024
Q2
$1.38M Sell
32,862
-10,289
-24% -$483K 0.01% 2328
2024
Q1
$1.62M Sell
43,151
-18,017
-29% -$392K 0.01% 2236
2023
Q4
$656K Buy
61,168
+50,521
+475% +$437K ﹤0.01% 2811
2023
Q3
$107K Sell
10,647
-17,133
-62% -$198K ﹤0.01% 3550
2023
Q2
$330K Buy
27,780
+14,613
+111% +$195K ﹤0.01% 2908
2023
Q1
$159K Buy
+13,167
New +$219K ﹤0.01% 2869

Other funds holding JANX